Paper Details

  1. Home
  2. Paper Details

Relapse in Dementia-related Psychosis and Clinical Decisions.

Author: DevanandDavangere P, FoffErin P, Soto-MartinMaria

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This abstract discusses the challenges of treating dementia-related psychosis (DRP), a condition characterized by hallucinations and delusions in patients with dementia. While antipsychotics are often used off-label, their efficacy is limited, and there are significant safety concerns. The need for new, well-tolerated therapies that effectively reduce DRP symptoms is highlighted.
Paper Details　
Original Abstract of the Article :
Patients with dementia can experience hallucinations and delusions because of their underlying neurodegenerative condition, a syndrome known as dementia-related psychosis. Dementia-related psychosis contributes to morbidity and mortality among patients with dementia and increases the burden on careg...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132239/

データ提供：米国国立医学図書館（NLM）

Navigating Dementia-Related Psychosis: A Complex Challenge

Dementia-related psychosis, characterized by hallucinations and delusions, poses a significant challenge for individuals with dementia and their caregivers. This complex condition requires a multifaceted approach, but currently, there's no specific pharmacological treatment approved in the United States. The study explores the use of antipsychotics as off-label treatment for dementia-related psychosis, highlighting the need for careful monitoring and management due to potential safety concerns.

Relapse in Dementia-Related Psychosis: A Critical Issue

One of the key concerns highlighted in the study is the risk of relapse after discontinuing antipsychotic treatment. This emphasizes the need for ongoing monitoring and careful evaluation of patients to determine the optimal course of treatment.

Dementia Care: A Multifaceted Approach

Effective management of dementia-related psychosis requires a multifaceted approach that considers both medication and non-pharmacological interventions.

Dr.Camel's Conclusion

This study underscores the complexity of dementia-related psychosis and the need for innovative treatments. Finding effective, safe, and well-tolerated therapies for this challenging condition is crucial for improving the lives of individuals with dementia and their families.

Date :
  1. Date Completed 2022-05-31
  2. Date Revised 2023-09-22
Further Info :

Pubmed ID

35137699

DOI: Digital Object Identifier

PMC9132239

Related Literature

Article Analysis
・Effective treatment of dementia
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.